相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intraductal Carcinoma of the Prostate as a Cause of Prostate Cancer Metastasis: A Molecular Portrait
Helen Pantazopoulos et al.
CANCERS (2022)
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Vivek Narayan et al.
NATURE MEDICINE (2022)
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer
Jonathan Epstein et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2021)
The 2019 International Society of Urological Pathology Consensus Conference on Prostate Cancer Grading
Geert J. L. H. van Leenders et al.
EUROPEAN UROLOGY (2021)
Intraductal Carcinoma of the Prostate: A Guide for the Practicing Pathologist
Murali Varma
ADVANCES IN ANATOMIC PATHOLOGY (2021)
Use ggbreak to Effectively Utilize Plotting Space to Deal With Large Datasets and Outliers
Shuangbin Xu et al.
FRONTIERS IN GENETICS (2021)
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes
Carla Calagua et al.
CLINICAL CANCER RESEARCH (2021)
The tumor microenvironment and immune responses in prostate cancer patients
J. T. W. Kwon et al.
ENDOCRINE-RELATED CANCER (2021)
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Filippo Veglia et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
Emmanuel S. Antonarakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression
Goutam Chakraborty et al.
CLINICAL CANCER RESEARCH (2020)
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
James L. Gulley et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy
Martin C. Tom et al.
JOURNAL OF UROLOGY (2019)
Advances in cancer immunotherapy 2019-latest trends
Stephan Kruger et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The Prognostic Value of the Proportion and Architectural Patterns of Intraductal Carcinoma of the Prostate in Patients with De Novo Metastatic Prostate Cancer
Jinge Zhao et al.
JOURNAL OF UROLOGY (2019)
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade
Wassim Abida et al.
JAMA ONCOLOGY (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER plus Breast Cancer
Andreas Heindl et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Prognostic parameter for high risk prostate cancer patients at initial presentation
Masashi Kato et al.
PROSTATE (2018)
Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER plus Breast Cancer
Andreas Heindl et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Novel nomograms for castration- resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer
Jinge Zhao et al.
BJU INTERNATIONAL (2018)
Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer
Harsimar B. Kaur et al.
MODERN PATHOLOGY (2018)
Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories
Laura H. Porter et al.
EUROPEAN UROLOGY (2017)
A Prostate Cancer Nimbosus'': Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies
Melvin L. K. Chua et al.
EUROPEAN UROLOGY (2017)
Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study
Thorstein Saeter et al.
PROSTATE (2017)
Population-based study of the incidence and survival for intraductal carcinoma of the prostate
Brian F. Dinerman et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy
Jinge Zhao et al.
ONCOTARGET (2017)
Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization
Michael C. Haffner et al.
JOURNAL OF PATHOLOGY (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours
Peter A. Humphrey et al.
EUROPEAN UROLOGY (2016)
The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation
Masashi Kato et al.
MODERN PATHOLOGY (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
Beyond immune density: critical role of spatial heterogeneity in estrogen receptor-negative breast cancer
Sidra Nawaz et al.
MODERN PATHOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Is There any Prognostic Impact of Intraductal Carcinoma of Prostate in Initial Diagnosed Aggressively Metastatic Prostate Cancer?
Tao Zhao et al.
PROSTATE (2015)
Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort
Dominique Trudel et al.
EUROPEAN JOURNAL OF CANCER (2014)
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Gregory T. Motz et al.
NATURE MEDICINE (2014)
Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression
G. Comito et al.
ONCOGENE (2014)
Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens
Kyosuke Kimura et al.
PROSTATE (2014)
Infiltration of CD8+Lymphocytes is an Independent Prognostic Factor of Biochemical Failure-Free Survival in Prostate Cancer
Nora Ness et al.
PROSTATE (2014)
Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer
Katri A. Leinonen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
High tissue density of FOXP3+T cells is associated with clinical outcome in prostate cancer
Anna Flammiger et al.
EUROPEAN JOURNAL OF CANCER (2013)
CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3+ regulatory T cells with respect to lethal prostate cancer
Sabina Davidsson et al.
MODERN PATHOLOGY (2013)
Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer
Anna Flammiger et al.
APMIS (2012)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Douglas G. Altman et al.
PLOS MEDICINE (2012)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The prognostic impact of M-CSF, CSF-1 receptor, CD68 and CD3 in prostatic carcinoma
E. Richardsen et al.
HISTOPATHOLOGY (2008)
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the prostate cancer clinical trials working group
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance
Charles C. Guo et al.
MODERN PATHOLOGY (2006)
The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer
PA McArdle et al.
BRITISH JOURNAL OF CANCER (2004)
分享论文
